Business
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100
CHICAGO, July 23, 2025--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S.
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/fd48eca480e2ecaafd6d2a6743305885"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/l_grTTPx9svzGVrTZT1f8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/fd48eca480e2ecaafd6d2a6743305885","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/KVI3GcsHLDQfNoHUrPxSag--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/fd48eca480e2ecaafd6d2a6743305885","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Increased R&D investments to integrate AI on devices across disease states designed to boost productivity, efficiency, and diagnostic confidence for healthcare professionals, and drive the company’s long-term growth","length":219,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Milestone advances GE HealthCare’s goal of attaining more than 200 authorizations by 2028","length":89,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":308,"olType":false},{"type":"text","content":"CHICAGO, July 23, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S.","length":251,"tagName":"p"},{"type":"text","content":"This milestone reflects GE HealthCare’s continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey. Smart devices, software, and cloud-based solutions, which are central to GE HealthCare’s precision care strategy, help enhance outcomes for patients, improve the daily work of care teams, and boost healthcare professional efficiency. These AI-enabled devices help solve customer challenges and are in high demand, which contributes to orders, revenue, and growth for the company. The momentum demonstrates GE HealthCare’s progress toward achieving its goal of securing more than 200 authorizations.","length":711,"tagName":"p"},{"type":"text","content...